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Abstract
Streptococcus pyogenes (group A streptococcus, GAS) is a major cause of necrotizing soft tissue infection (NSTI). On rare occasions, other
b-haemolytic streptococci may also cause NSTI, but the signiﬁcance and nature of these infections has not been thoroughly investigated. In
this study, clinical and molecular characteristics of NSTI caused by GAS and b-haemolytic Streptococcus dysgalactiae subsp. equisimilis of
groups C and G (GCS/GGS) in western Norway during 2000–09 are presented. Clinical data were included retrospectively. The bacterial
isolates were subsequently emm typed and screened for the presence of genes encoding streptococcal superantigens. Seventy cases were
identiﬁed, corresponding to a mean annual incidence rate of 1.4 per 100 000. Sixty-one of the cases were associated with GAS, whereas
GCS/GGS accounted for the remaining nine cases. The in-hospital case fatality rates of GAS and GCS/GGS disease were 11% and 33%,
respectively. The GCS/GGS patients were older, had comorbidities more often and had anatomically more superﬁcial disease than the GAS
patients. High age and toxic shock syndrome were associated with mortality. The Laboratory Risk Indicator for Necrotizing Fasciitis
laboratory score showed high values (≥6) in only 31 of 67 cases. Among the available 42 GAS isolates, the most predominant emm types
were emm1, emm3 and emm4. The virulence gene proﬁles were strongly correlated to emm type. The number of superantigen genes was
low in the four available GCS/GGS isolates. Our ﬁndings indicate a high frequency of streptococcal necrotizing fasciitis in our community.
GCS/GGS infections contribute to the disease burden, but differ from GAS cases in frequency and predisposing factors.
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Introduction
Necrotizing soft tissue infections (NSTI) and the dominating
subgroup, necrotizing fasciitis (NF), are rare and serious
conditions characterized by rapid spread along tissue planes
with development of necrosis [1–3]. NSTI is a heterogeneous
group of infections affecting various groups of patients, caused
by many microbes, leading to a wide range of clinical
manifestations. Data on incidence, predisposing conditions
and prognostic factors diverge, probably reﬂecting differences
in inclusion criteria and study populations in various studies
[3]. The classiﬁcation of NSTI has traditionally been based on
microbiological ﬁndings: type I infections are polymicrobial,
whereas type II infections are monomicrobial, and most often
caused by Streptococcus pyogenes (group A streptococcus;
GAS) [1–3]. To get more reproducible data it may be
appropriate to investigate the different types of NSTI
separately. NSTI caused by GAS seems to represent a speciﬁc
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disease entity, characterized by frequent development of shock
and high mortality. A substantial proportion of the patients
have no predisposing comorbidity. The unique pathogenesis of
streptococcal fasciitis is probably dependent on many virulence
factors. Although the bacterial virulence proﬁle appears to be
critical for the development of NSTI and streptococcal toxic
shock syndrome (STSS), the distribution of emm types,
superantigens and other virulence factors varies in strepto-
coccal isolates associated with severe invasive disease [4–6].
Only a few previous studies have investigated the character-
istics of streptococcal NSTI in detail [7,8]. These studies have
been conﬁned to GAS infections, but recent studies have
shown that S. dysgalactiae subsp. equisimilis of groups C and G
(GCS and GGS) also have the ability to cause NSTI or STSS
[9–13]. These two latter groups of streptococci share many
virulence factors with GAS. Rarely, they even possess the
group A carbohydrate antigen [14], which might lead to
misidentiﬁcation in the laboratory. To avoid this, additional
tests for species identiﬁcation can be used, although currently
many laboratories use only serotype speciﬁcity on b-haemo-
lytic streptococci and use the terms GAS and GCS/GGS.
Streptococci within the Streptococcus anginosus group may also
possess the group A, C or G antigens, but those can be easily
discerned in the laboratory. In this study we describe
incidence, clinical aspects and bacterial virulence gene proﬁles
in NSTI caused by GAS and b-haemolytic GCS and GGS
treated at Haukeland University Hospital, Norway during
2000–2009. The usefulness of the laboratory-based Laboratory
Risk Indicator for Necrotizing Fasciitis (LRINEC) score for
diagnosing streptococcal NSTI was also evaluated [15].
Patients and Methods
Study population, case deﬁnition and clinical parameters
Haukeland University Hospital (HUH) is a teaching hospital in
Bergen, Norway. Patients admitted to the neighbouring
Haraldsplass Deaconal Hospital are transferred to and treated
at HUH when NSTI is suspected. These two hospitals have
1100 and 170 somatic beds, respectively. Incidence was
calculated on the basis of cases from the catchment area of
these two hospitals. The population in this area increased from
c.347 000 to 387 000 inhabitants during the study period.
HUH is also a tertiary hospital for a total of c.1 000 000
people. All cases of NSTI caused by GAS, GCS and GGS
treated at HUH during 2000–2009 were retrospectively
registered. Only the cases meeting surgical, clinical and
microbiological criteria for streptococcal NSTI were included.
NSTI was deﬁned as necrotizing cellulitis or fasciitis as
described previously [16]. Cases with surgical evidence of
infectious myositis were also included, but cases of pyomyo-
sitis, deﬁned as pus within individual muscle groups, were
excluded [17]. Evaluation was based upon macroscopic
ﬁndings during surgery, histological examination or post-mor-
tem analyses. Removal of tissue was considered mandatory for
the diagnosis of NSTI, apart from cases where surgical
treatment was withheld because the chances of survival were
considered to be very low. STSS was deﬁned using criteria
originally meant for GAS [18]. Streptococcal aetiology was
deﬁned by the isolation of GAS, GCS or GGS from blood or
the infected soft tissue. Cases were not included if the
streptococci were isolated from a mixed ﬂora with more than
two species. Relevant data were obtained from the medical
records using a standard abstraction sheet. Age, gender,
demographic information, comorbidities and laboratory data at
the time of admission were recorded. Microbiological culture
results, antibiotic and surgical treatment, per operative
ﬁndings, relevant adjunctive therapy, and outcome were also
recorded. Written informed consent from the patients was
not needed, as judged by the Regional Committee of Medical
and Health Research Ethics. The study was approved by the
privacy ombudsman of HUH.
Bacterial identiﬁcation
All GAS, GCS or GGS were b-haemolytic and formed large
colonies on blood agar. Serogroup-speciﬁcity was determined
using a rapid agglutination test (Oxoid, Basingstoke, Hamp-
shire, UK). These methods of identiﬁcation imply that rare
cases of S. dysgalactiae subsp. equisimilis of serogroup A may
have been misidentiﬁed as S. pyogenes (GAS).
Emm typing
Extraction of chromosomal DNA after mechanical lysis of the
cell wall and emm typing were performed as previously
described [19]. The following primers were used for initial
emm ampliﬁcation and sequencing in both directions: 5′-GG
G-AAT-TCT-ATT-SGC-TTA-GAA-AAT-TAA-3′ (forward pri-
mer) and 5′-GCA-AGT-TCT-TCA-GCT-TGT-TT-3′ (reverse
primer) [20]. Assignment of emm types was done using the
CDC Streptococcus Laboratory emm type database (http://
www.cdc.gov/ncidod/biotech/strep/strepindex.htm).
Detection of streptococcal superantigen genes and SlaA
A multiplex PCR with speciﬁc primer pairs for the 11 exotoxin
genes speA, speC, speG, speH, speI, speJ, speK, speL, speM, ssa
and smeZ was used as described in detail elsewhere [21]. To
include allelic variations of the smeZ gene we also used simplex
PCR with a previously described primer pair [22]. Simplex
PCR ampliﬁcations of speGdys, a speG orthologue found in
S. dysgalactiae subsp. equisimilis, and the gene encoding strep-
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tococcal phospholipase A2 (SlaA) were performed with
primers described previously [9]. The speGdys primers ampli-
ﬁed segments of equal size in both speGdys and speG, whereas
the speG primers ampliﬁed only speG. Hence, all the GAS and
GCS/GGS were screened for the presence of the 11 GAS
superantigen genes (SAg) and SlaA, whereas only the GCS/
GGS were subjected to PCR with the speGdys primers.
Statistical analysis
Data were analysed using SPSS PASW STATISTICS, version 20.0
(SPSS Inc, Chicago, IL, USA). Categorical data were analysed
using Fisher’s exact test. Non-parametric data (age) were
analysed using the Mann–Whitney U-test. Because multiple
comparisons were performed, both unadjusted and Holm–
Bonferroni-corrected p values were calculated. A two-sided
p-value ≤0.05 was considered statistically signiﬁcant. To
identify predictors of mortality, univariate analysis of several
factors previously reported to be associated with mortality
was ﬁrst performed. Multivariate logistic regression analysis
was performed choosing factors representing both predispos-
ing conditions and acute disease severity and with low
multicollinearity and low proportion of missing values.
Results
Seventy patients treated for NSTI caused by GAS, GCS or GGS
in the period 2000–2009 were identiﬁed and included in the
study. The mean annual incidence was 1.4 per 100 000
population. The annual incidence varied greatly, ranging from
0.29 to 2.84 per 100 000. Sixty-four of the infections were
community-acquired, and no cases were epidemiologically
linked. Sixty-one of the patients had NSTI caused by GAS,
whereas GCS accounted for two and GGS for seven cases.
Staphylococcus aureus was co-cultured with GAS in two samples
and together with GGS in two samples. Median age at
presentation was 55.5 years (range 4–87 years); and 55 and
72 years among GAS and GCS/GGS patients, respectively
(p 0.11). Only one patient was below 16 years of age, and 47
of the patients were men. An overview of the clinical features,
laboratory data, predisposing factors and outcome is shown in
Table 1. In almost half of GAS patients both the muscle fascia
(aponeurosis) and muscle tissue were affected, whereas only
two of the patients with GCS/GGS infection had such signs of
deep tissue involvement. A minority of the patients had only
necrosis of subcutaneous tissue/superﬁcial fascia without evi-
dence of involvement of the muscle fascia or muscle. STSS was
diagnosed more often in patients with muscle involvement than
in the other patients (p 0.04). The lower limb was the site of
infection in 35 of the patients. Most patients had positive tissue
cultures even though most of them had received antibiotics
before surgery. Only about half of the patients had an LRINEC
laboratory score ≥6, which has been associated with a high
probability of NSTI in a previous study on NSTI and cellulitis
[15]. Signiﬁcant comorbidity was present in less than half of the
GAS patients, most commonly cardiovascular disease. Surgical
treatment within 24 h of admittance was performed in 45
patients, and the median number of operative procedures
performed per patientwas three. The amputation ratewas 8.6%.
Clindamycin was included in the initial antibiotic treatment for
40 patients. Only one patient was treated with intravenous
immunoglobulin, and none were treated with hyperbaric
oxygen. The in-hospital case fatality rates (CFR) of GAS and
TABLE 1. Clinical characteristics and outcome















Subcutaneous involvement onlyb,c 5 59 3 7 8 66 0.033 (0.363)
Muscle involvementb 26 55 2 9 28 64 0.278
STSS 28 61 5 9 33 70 0.726
Laboratory data
Blood culture positive 27 61 2 9 29 70 0.289
Tissue culture positive 44 60 8 9 52 69 0.435
LRINEC score ≥6d 29 58 2 9 31 67 0.161
Predisposing factors
Age ≥65 years 15 61 5 9 20 70 0.107
Comorbidity 29 61 7 9 36 70 0.152
Outcome
Amputations 6 61 0 9 6 70 1.000
Died in hospital 7 61 3 9 10 70 0.112
Died before 90 days 12 61 3 9 15 70 0.392
GAS, group A streptococcus; GCS, group C streptococcus; GGS, group G streptococcus; STSS, streptococcal toxic shock syndrome; LRINEC, Laboratory risk indicator for
necrotizing fasciitis.
aFor the difference between GAS and GCS/GGS. Fisher’s exact test. In parenthesis: p value corrected for multiple comparisons (Holm–Bonferroni method).
bBased on macroscopic ﬁndings during surgery.
cMuscle fascia (aponeurosis) and muscle tissue not involved.
dBased on values for C-reactive protein, leucocytes, haemoglobin, creatinine, glucose and sodium [15].
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GGS disease were 11% and 33%, respectively, whereas the CFR
after 3 months were 20% and 33%, respectively.
The impact of various factors on in-hospital mortality is
presented in Table 2. Premorbid factors (age ≥65 years and
comorbid heart disease) as well as disease manifestations
(STSS, muscle involvement) and treatment factors (fewer than
three surgical debridements) were associated with mortality in
the univariate analysis. When corrected for multiple compar-
isons, muscle involvement was not a signiﬁcant factor. The
association between mortality and few debridements could be
explained by the fact that in ﬁve of the six patients with fewer
than three debridements who died, surgical treatment was
withheld because of a moribund state. In a logistic regression
analysis age, STSS and comorbidity were chosen as predictor
variables. Independent predictors of mortality in this model
were increased age (OR per year 1.095, 95% CI 1.023–1.172;
p 0.009) and STSS (OR 9.596; 95% CI 1.016–90.640; p 0.048).
Forty-two GAS isolates were available for molecular
analysis. The emm type distribution in relation to SAg gene
proﬁle of the GAS isolates is shown in Table 3. Thirteen
isolates possessed emm1. All isolates except those possessing
emm4.0 and emm77.0 contained speG, and all but three
isolates, belonging to emm2, emm49 and emm96 contained
smeZ. All the 13 isolates of emm1 showed identical SAg
proﬁles and contained the phage-mediated superantigen speA
and the chromosomally encoded speG, speJ and smeZ. For
other emm types found in more than one case, the isolates
sharing the same emm type also had the same virulence gene
proﬁle in all but four isolates. The four available GCS/GGS
isolates belonged to four different emm types (stC74a.0,
stG10.0, stG2574.0, stG6.3). The speGdys gene was found in
isolates of the former three of these emm types. GAS SAg or
SlaA genes were not identiﬁed in GCS/GGS.
There was no signiﬁcant correlation between fatal outcome
and speciﬁc virulence gene proﬁles, although three of the six
genotyped GAS isolates associated with fatal outcome had
emm types previously reported to give a CFR above 30% when
associated with NF [23].
Discussion
The present study is among the largest series of streptococcal
NSTI reported to date. Several large series of NSTI have been
TABLE 2. Predictors of in-hospital mortality
Survivals (n = 60) Deaths (n = 10)
OR (95% CI)a p valuebNo. with characteristic Evaluable cases No. with characteristic Evaluable cases
STSS 24 60 9 10 13.50 (1.61–113.55) 0.005 (0.045)
Muscle involvementc 20 55 8 9 14.00 (1.63–120.22) 0.008 (0.056)
Bacteraemia 23 60 6 10 2.41 (0.61–9.48) 0.299
Surgery >24 hd 22 60 3 10 0.74 (0.17–3.16) 1.000
Surgical revisions <3e 8 60 6 10 9.75 (2.25–42.32) 0.003 (0.033)
Not clindamycind 27 60 3 10 0.52 (0.12–2.22) 0.498
Age ≥65 years 13 60 7 10 8.44 (1.91–37.26) 0.004 (0.040)
Comorbidity 30 60 6 10 1.50 (0.384–5.860) 0.736
Heart disease 6 60 5 10 9.00 (2.01–40.30) 0.006 (0.048)
LRINEC score ≥6f 26 58 5 9 1.54 (0.37–6.32) 0.723
emm type 1/3/5/12/18/87/89g 19 36 4 6 1.79 (0.29–11.04) 0.673
STSS, streptococcal toxic shock syndrome; LRINEC, Laboratory risk indicator for necrotizing fasciitis.
aORs and 95% CIs were estimated using univariate logistic regression analysis.
bFisher’s exact test. In parentheses: p values corrected for multiple comparisons (Holm–Bonferroni method).
cBased on macroscopic ﬁndings during surgery.
dFrom admittance.
eFewer than three surgical revisions before discharge/death.
fBased on values for C-reactive protein, leucocytes, haemoglobin, creatinine, glucose and sodium [15].
gemm types in GAS cases associated with case fatality rate >30% in necrotizing fasciitis [23].
TABLE 3. Virulence genes of 42 group A streptococcus isolates
emm typea No. speA speC speG speH speI speJ speK speL speM ssa smeZ SlaA
emm1.0 13b +  +   +     + 
emm3.1 5 +  +    +   + + +
emm4.0 4 +(1)/ +/(1)        + + 
emm9.0 2   +    +/   + + 
emm28.0 3 +(1)/ + +  +  +(2)/    + +(2)/
emm82.0 2  + + + +      + 
emm89.0 2  +/ +   +/ +/    + +/
Nineteen group A streptococcus isolates were not available for analysis.
aOther emm types (n = 1): emm2.0: speC+speG, emm6.0: speA+ speC+speG +speK+smeZ+SlaA, emm12.0: speC+speG +speH+speI+smeZ, emm43.4: speG+speK+smeZ+SlaA,
emm49.0: speC+ speG+speH+speI+speL, emm75.0: speC+speG +speL+speK+speM+smeZ+slaA, emm77.0: speC+smeZ, emm78.3: speG+smeZ, emm87.0: speG+speH+speI+s-
peJ+smeZ, emm96.0: speC+speG, emm102b: speC+speG +speJ+smeZ.
bIncluding one isolate with subtype 1.22.
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published during the past few years, but none of these
presented more than a few clinical parameters in relation to
bacterial aetiology [24–27]. Detailed and stringent clinical and
microbiological information from large series on streptococcal
NSTI is lacking, apart from prospective studies from Ontario,
Canada performed in the 1990s [7,8]. Compared with the
incidence of GAS NF in prospective studies from Canada
(0.08–0.49/100 000/year) and Europe (0.22–0.6/100.000/year)
a relatively high frequency of streptococcal NSTI was observed
in our study, and GCS/GGS infections contribute to the
disease burden [8,23,28]. Differences in reported incidence
rates may also be explained by the use of imprecise inclusion
criteria. In studies on NF, cases with engagement of the muscle
fascia are probably often the only ones included. Excluding
cases without such involvement might be inappropriate,
because streptococcal disease with rapid spread along the
subcutaneous tissue planes probably represents the same
disease as the slightly more deeply situated infections. To
improve comparability of studies, it may be more feasible to
use the term NSTI rather than NF, as suggested by several
authors, implying that cases are included irrespective of soft
tissue level [2,3,29,30]. Almost half of our patients had
involvement of the muscle fascia and muscle tissue. The
incidence in our study is therefore high even when comparing
only deﬁnite NF cases.
The high proportion of patients with intraoperative signs of
muscle tissue involvement shows that streptococcal infections
not only spread along tissue planes; they often disrespect
borders between tissue compartments. GAS-infected patients
had muscle tissue involvement more often than GCS/
GGS-infected patients. However, the difference was not
statistically signiﬁcant, and the number of GCS/GGS cases
was low.
During the study period, <5% of all NSTI (type I and type II
infections) at our hospital were culture negative (data not
shown). This leads us to believe that almost all streptococcal
cases treated in our institution were included in this study. High
bacterial load and reduced bioavailability of antibiotics are
known to reduce the effect of antibiotics in NSTI. These
observations are supported by the high number of positive tissue
cultures among the included patients, although most patients
received antibiotic treatment before surgical intervention.
The LRINEC score was an insensitive tool for the diagnosis
of streptococcal NSTI in our patients. A possible explanation
might be the high awareness of NSTI in our region, contrib-
uting to early hospitalization and thus a low LRINEC score at
admission. The usefulness of this score has been questioned
also in several other recent studies [2,3]. Early recognition of
typical symptoms and signs that requires surgical exploration
therefore remains the major tool in the diagnosis of strepto-
coccal NSTI [3]. High-quality education and training of the
physicians involved is therefore essential.
The signiﬁcant proportion of streptococcal NSTI caused by
GCS/GGS in our study conﬁrms the ability of these strepto-
cocci to cause severe soft tissue infections. In accordance with
other studies of invasive GCS and GGS disease, our GCS/
GGS-infected patients tended to be older and more often had
underlying disease than GAS patients [9–12]. Among the 61
GAS cases 27 neither had comorbidity nor age ≥65 years,
supporting the impression that GAS are highly virulent bacteria
able to cause particularly severe soft tissue infections even in
patients without predisposing conditions [7].
Although the CFR of GAS infections in the present study
was relatively low, several factors were found to be associated
with mortality. A high CFR in those with muscle tissue
involvement found here is consistent with the high mortality
previously reported in streptococcal myositis, a particularly
severe form of NSTI [31]. Our ﬁndings differ from observa-
tions reported in a study of NSTI where the presence of
myonecrosis did not inﬂuence mortality. This is possibly
explained by a low proportion of streptococcal disease [29].
We found that STSS and age are independent predictors of
mortality. These results are consistent with those from other
studies [7,8,25,26]. Even though early surgery or clindamycin
treatment was not signiﬁcantly associated with favourable
outcome in this material, these factors were protective in
other series [1].
Certain emm types, like emm1, emm3, emm4 and emm28,
dominated our GAS samples. Particularly emm1 and emm3
have previously been linked to NSTI, STSS and mortality,
probably indicating that isolates within certain emm types are
genetically ﬁt to produce more severe disease manifestations
[4,23]. Nevertheless, the overall emm type diversity in our
material was substantial. This, along with a lack of correlation
between emm type/superantigen gene proﬁle and fatal out-
come, indicates that host susceptibility is a key factor in the
development and course of streptococcal NF. The low content
of superantigen genes detected in GCS/GGS probably
reﬂects the fact that these virulence factors are not a
prerequisite for the development of NSTI caused by these
bacteria [9,10,12].
The major limitations of this study arise from the retro-
spective inclusion of data. Such a design makes it difﬁcult to
perform a detailed and standardized characterization of all the
patients, including preoperative clinical ﬁndings, macroscopic
ﬁndings upon surgery and comprehensive laboratory analyses.
In conclusion, we report a relatively high incidence of
streptococcal NSTI in our region of western Norway. GCS and
GGS infections contributed to the disease burden, but they
differ from GAS cases in frequency and predisposing factors.
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The overall mortality rates were relatively low, probably
related to well-implemented routines of early surgery, appro-
priate antibiotic therapy and adequate supportive measures.
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